Role of Sugars (Sucrose, Trehalose) in Lyophilization: Mechanisms, Stability, and Formulation Design

5/29/20264 min read

Introduction

Among all excipients used in pharmaceutical lyophilization, few have had a greater impact on the successful stabilization of biologics than sugars. The widespread use of sucrose and trehalose has transformed the development of freeze-dried formulations by enabling the stabilization of proteins, monoclonal antibodies, vaccines, peptides, enzymes, and more recently, nucleic acid-based therapeutics.

While sugars are often categorized simply as formulation excipients, their actual role is far more significant. In many biologic products, sugars serve as the primary stabilization mechanism protecting sensitive molecules from the stresses associated with freezing, drying, storage, and reconstitution.

Their effectiveness stems from a unique combination of physicochemical properties, including:

  • Hydrogen bonding capability

  • Glass-forming behavior

  • High vitrification potential

  • Molecular immobilization effects

  • Moisture buffering capacity

As a result, sucrose and trehalose have become cornerstone excipients in modern lyophilization science.

This article builds upon concepts discussed in:

Why Biologics Require Stabilization

Biological molecules exist in highly organized structures maintained by weak intermolecular forces.

Proteins, for example, rely on:

  • Hydrogen bonding

  • Electrostatic interactions

  • Hydrophobic effects

  • Van der Waals forces

In aqueous environments, water plays a critical structural role.

During lyophilization:

  • Water freezes

  • Water is subsequently removed through sublimation and desorption

  • Hydration shells disappear

Without adequate stabilization, biomolecules may undergo:

  • Unfolding

  • Aggregation

  • Denaturation

  • Loss of biological activity

  • Reduced shelf life

The primary function of sugars is to minimize these destabilizing effects.

Why Sugars Are Particularly Effective

Not all excipients provide equivalent stabilization.

Sucrose and trehalose possess several properties that make them exceptionally useful in freeze-dried formulations.

They:

  • Remain predominantly amorphous after drying

  • Form stable glassy matrices

  • Interact strongly with proteins through hydrogen bonding

  • Reduce molecular mobility

  • Improve storage stability

These properties allow sugars to provide protection during both:

  • Freezing

  • Drying

  • Long-term storage

This dual functionality means they often serve as both cryoprotectants and lyoprotectants.

The Water Replacement Hypothesis

One of the most widely accepted explanations for sugar-mediated stabilization is the water replacement hypothesis.

In solution, proteins are surrounded by hydration layers.

These water molecules:

  • Stabilize native conformation

  • Maintain molecular flexibility

  • Support structural integrity

During drying, water is removed.

This creates a risk that:

  • Hydrogen-bond networks collapse

  • Protein conformation changes

  • Activity decreases

Sugars compensate by replacing lost water interactions.

They form hydrogen bonds directly with exposed functional groups on proteins and other biomolecules.

This helps preserve:

  • Secondary structure

  • Tertiary structure

  • Functional activity

Even after dehydration, many native structural features can be retained.

Vitrification and Glass Formation

Another critical stabilization mechanism is vitrification.

As drying progresses, sucrose and trehalose form amorphous glassy matrices that surround biomolecules.

These glasses:

  • Restrict molecular movement

  • Reduce diffusion rates

  • Limit degradation reactions

  • Immobilize sensitive structures

This phenomenon is closely linked to:

Glass Transition Temperature in Freeze Drying (Tg′ vs Tg Explained).

The higher the glass transition temperature relative to storage conditions, the greater the expected stability.

Vitrification is considered one of the most important reasons sugars are effective in lyophilized biologic formulations.

Sucrose in Lyophilization
Characteristics of Sucrose

Sucrose is one of the most commonly used excipients in freeze-dried pharmaceuticals.

Key advantages include:

  • Strong protein stabilization

  • Excellent glass-forming properties

  • Broad regulatory acceptance

  • Extensive industry experience

Sucrose typically remains amorphous during freeze drying, allowing it to maintain a continuous protective matrix around biomolecules.

Advantages of Sucrose

Sucrose offers:

  • Effective cryoprotection

  • Effective lyoprotection

  • Good reconstitution characteristics

  • Compatibility with many proteins

Because of its extensive use history, sucrose remains a preferred stabilizer in many commercial biologic products.

Limitations of Sucrose

Despite its advantages, sucrose has limitations.

These include:

  • Lower glass transition temperature compared with trehalose

  • Sensitivity to moisture uptake

  • Potential hydrolytic degradation under certain conditions

For highly demanding stability requirements, alternative or complementary excipients may be necessary.

Trehalose in Lyophilization
Characteristics of Trehalose

Trehalose has gained significant attention as a superior stabilizer in many applications.

It possesses:

  • High glass transition temperature

  • Exceptional vitrification behavior

  • Strong hydrogen-bonding capability

  • Excellent storage stability

Trehalose occurs naturally in organisms capable of surviving extreme dehydration, which has inspired extensive pharmaceutical research.

Advantages of Trehalose

Compared with sucrose, trehalose often provides:

  • Higher Tg values

  • Improved thermal stability

  • Enhanced storage robustness

  • Greater resistance to moisture-induced plasticization

These properties make trehalose particularly attractive for:

  • Vaccines

  • Monoclonal antibodies

  • Advanced biologics

  • Nucleic acid therapeutics

Limitations of Trehalose

Trehalose is not universally superior.

Potential disadvantages include:

  • Higher cost

  • Different reconstitution characteristics

  • Formulation-specific compatibility issues

Ultimately, excipient selection must be based on experimental evaluation rather than theoretical preference.

Sucrose Versus Trehalose

Although both sugars function through similar stabilization mechanisms, important differences exist.

Sucrose generally offers:

  • Extensive regulatory history

  • Broad formulation compatibility

  • Cost efficiency

Trehalose often provides:

  • Higher glass transition temperatures

  • Greater storage stability

  • Improved thermal robustness

The optimal choice depends on:

  • Active ingredient characteristics

  • Stability objectives

  • Storage requirements

  • Manufacturing constraints

In many cases, both sugars are evaluated during formulation screening.

Influence on Glass Transition Temperature

Sugars significantly influence both:

  • Tg′ (glass transition of the freeze-concentrated phase)

  • Tg (glass transition of the dried product)

Higher Tg values generally contribute to:

  • Reduced molecular mobility

  • Improved stability

  • Lower collapse risk

This relationship directly affects:

The ability of sugars to create rigid amorphous matrices is one of their greatest formulation advantages.

Influence on Drying Behavior

Although sugars primarily serve stabilization functions, they also affect process performance.

Sugar concentration may influence:

  • Viscosity

  • Ice crystal formation

  • Freeze concentration behavior

  • Product resistance

These effects can alter:

  • Drying kinetics

  • Cycle duration

  • Residual moisture levels

This connects closely with:

Sugars in Modern Biopharmaceutical Products
Monoclonal Antibodies

Sugars help reduce:

  • Aggregation

  • Structural degradation

  • Potency loss

See:
Lyophilization of Monoclonal Antibodies.

Vaccines

Sugar-based stabilization is critical for maintaining:

  • Antigen structure

  • Biological activity

  • Long-term storage stability

See:
Vaccine Stabilization Using Freeze Drying.

mRNA Therapeutics

Modern mRNA systems require stabilization of both:

  • Nucleic acids

  • Lipid nanoparticle delivery systems

Sugars play an increasingly important role in this area.

See:
Lyophilization of mRNA-Based Drugs and Vaccines.

Common Misconceptions About Sugars

One misconception is that all sugars provide equivalent stabilization.

In reality, molecular structure strongly influences:

  • Glass formation

  • Water interactions

  • Stability behavior

Another misconception is that increasing sugar concentration always improves stability.

Excessive concentrations may:

  • Increase viscosity

  • Alter reconstitution

  • Affect processability

  • Increase drying resistance

Effective formulation design requires balancing stabilization with manufacturability.

Future Perspectives

As biologics continue to grow in complexity, sugar-based stabilization strategies are evolving.

Current research focuses on:

  • Sugar combinations

  • Novel disaccharides

  • High-concentration biologics

  • Advanced vaccine platforms

  • mRNA stabilization technologies

The role of sugars is expected to remain central to future lyophilization innovation.

Conclusion

Sucrose and trehalose are among the most important excipients used in pharmaceutical lyophilization.

Through mechanisms including:

  • Water replacement

  • Vitrification

  • Molecular immobilization

  • Glass formation

they protect sensitive biomolecules from the stresses of freezing, drying, and storage.

Their ability to preserve stability while supporting manufacturability has made them indispensable tools in modern formulation development.

In contemporary freeze-drying science, sugars are far more than bulking agents or excipients—they are fundamental stabilization platforms that enable the successful development of advanced biopharmaceutical products.

Disclaimer
This article is provided solely for educational, scientific, and technical purposes related to pharmaceutical lyophilization. The content is originally written based on established pharmaceutical, biochemical, and engineering principles and does not reproduce copyrighted material, proprietary documentation, or text from any single published source. The information presented should not be interpreted as regulatory guidance, manufacturing instruction, validation protocol, or professional consulting advice. All formulation and process decisions should be supported by experimental studies, internal quality systems, applicable regulatory standards, and product-specific characterization. The author and publisher assume no responsibility for outcomes resulting from the application of this material in research, development, clinical manufacturing, or commercial production.

Updates

Latest news on lyophilization/freeze drying.

CONTACT

Subscribe

© 2025. All rights reserved.

NAvigation